Health Condition 1: P599- Neonatal jaundice, unspecified
Conditions
Interventions
Intervention1: Intervention arm-1 will receive zinc salt ( oral- 5mg/day)
Intervention arm-2 will receive zinc salt ( oral- 10mg/day)
: After randomization in intervention arm 1 & 2 neonates will rece
Sponsors
Gummalla Gyandeep
Eligibility
Inclusion criteria
Inclusion criteria: Neonates with Gestational age = 35 weeks admitted in NICU for phototherapy as per UK-NICE guideline.
Exclusion criteria
Exclusion criteria: 1)Severe hyperbilirubinemia( need of escalation therapy and exchange transfusion) 2)Major congenital abnormality 3) Sick neonate (sepsis, birth asphyxia, feed intolerance, mechanical ventilation, IEM) where oral feeding contraindicated. 4)Rebound hyperbilirubinemia who require phototherapy again 5) Maternal Phenobarbital intake.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be measured by comparing decrease in unconjugated serum bilirubin in both zinc with 5mg and 10 mg oral group along with placebo group.Timepoint: 1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes will be measured by comparing the duration of phototherapy, hospital stay, adverse events of the zinc and zinc levels pre and post phototherapy in intervention and placebo groups.Timepoint: 1 month | — |
Countries
India
Contacts
Public ContactGummalla Gyandeep
KALINGA INSTITUTE OF MEDICAL SCIENCES
Outcome results
None listed